A safe and effective cure for eye floaters is our goal – as soon as possible.
While scientific research is the solution, it’s essential that we lay the foundation to have this disease recognized as a serious issue by the medical community – meaning a cure can be developed faster.
We have outlined our Tri-Project Proposal below with details on how we can greatly accelerate scientific research and help us pressure the pharmaceutical industry to cure eye floaters.
The VDM Project is exploring ways to receive governmental grants, but this won’t be possible without eye floaters being recognized as a serious problem first. We can only complete the program with funding, and we need your help.
We are aiming to raise $10,000 per month to achieve our goals.
Con i risultati di questi progetti vitali, avremo la ricerca quantificabile da presentare agli istituti medici che capiranno il grave impatto delle miodesopsie - il che ci aiuterà a sviluppare una cura sicura ed efficace più presto.
Una cura sicura ed efficace per le miodesopsie è il nostro obiettivo - il più presto possibile.
While scientific research is the solution, it’s also essential that we have this disease recognized as a serious issue by the medical community and society at large. This way, a cure can be developed faster.
We have outlined with the VMR Research Foundation and Dr. J. Sebag a Tri-Project Proposal below with details on how we can greatly accelerate scientific research and help put pressure on the pharmaceutical industry to cure eye floaters.
The VDM Project is exploring ways to receive government grants, but this won’t be possible without eye floaters being recognized as a serious problem first. We can only complete the program with funding, and we need your help.
We are a team of eye floater sufferers from around the world, united to find a safe and effective cure for this disease. We support the VMR Research Foundation and work with other international institutes. The VDM Project is committed to scientific research that will result in clear vision – but we need your help. Find out more information at: www.vdmresearch.org
Il nostro obiettivo a breve termine è quello di curare questa malattia, e il nostro obiettivo a lungo termine è quello di prevenirla.
To do this, our researchers need to gain a better knowledge of eye floaters at a molecular level. For a cure to be found, a better understanding of eye floaters is essential. As a combined effort between the VMR Research Foundation and university laboratories in Belgium, Germany, Poland, Spain, and the United States , this project is fundamental to understanding how eye floaters develop, and how they can be treated safely today, as well as prevented tomorrow.
Near-sightedness (myopia) has a strong correlation with eye floaters, but the reason is currently unknown.
Project Two will assess the changes in the eyes of patients with eye floaters to better understand how and why this condition occurs. Due to myopia levels increasing dramatically worldwide (estimated to affect 5 billion people per year by 2050), this project is necessary to gain the attention of governments and medical institutes globally. Once we have sufficient data, funding toward a cure is much more likely, meaning a floater-free future for sufferers.
Una delle nostre strategie chiave per far riconoscere questa malattia dai governi, dagli istituti medici e dai ricercatori è quella di mostrare la diffusa prevalenza delle miodesopsie.
Currently, a questionnaire frequently used by the U.S. National Eye Institute does not adequately show how eye floaters negatively impact the lives of sufferers. We aim to change this. A new questionnaire created by the VMR Research Foundation specifically measures the negative impact of eye floaters with quantifiable metrics, so we can accurately measure the magnitude of this problem for individuals as well as populations. This vital questionnaire will greatly strengthen our ability to apply for medical research funding and is a key step to curing eye floaters. We also anticipate that this questionnaire will provide sufferers with feedback on the severity of their disease.
Solo con i fondi necessari possiamo completare questi progetti essenziali e ottenere dati in tempo reale che mostrano quanto possano essere debilitanti le miodesopsie.
Tutte le donazioni saranno assegnate alla proposta del Tri-Project di conseguenza, massimizzando la nostra capacità di completarle il prima possibile - il che significa che saremo più vicini a trovare una cura.
If you wish to donate but are unable to via this platform, you are welcome to via Wire Transfer:
Senior Research Scientist, Doheny Eye Institute/UCLA; professore di oftalmologia clinica, Geffen School of Medicine, UCLA; direttore fondatore, VMR Institute for Vitreous Macula Retina
Considerato una delle principali autorità sul vitreo, il Dr. Sebag è autore di 233 pubblicazioni accademiche, a partire da ottobre 2020.
Membro dell'American College of Surgeons e del Royal College of Ophthalmologists (Regno Unito), il Dr. Sebag ha tenuto conferenze nominative in tutto il mondo, più recentemente la Inaugural Robert Machemer Lecture alla European Society of Ophthalmology (2019). Nel 2006 il Dr. Sebag è stato inserito come membro dell'American Ophthalmological Society, presiedendo il comitato di programma nel 2016. Nel 2010 è stato selezionato come Fellow dell'ARVO, la principale organizzazione mondiale per la ricerca sugli occhi. Nel 2018 l'American Academy of Ophthalmology ha conferito al Dr. Sebag il Senior Career Achievement Award.
Nell'ultimo decennio il Dr. Sebag ha sostenuto la causa delle persone che soffrono di floaters vitreali sufficientemente gravi da meritare la diagnosi di miodesopsia degenerativa della vista, una condizione che può essere curata oggi con la vitrectomia, ma domani con approcci meno invasivi e persino con la prevenzione, il fine ultimo della medicina moderna.
Sostenere il progetto VDM farà sì che il domani accada prima.
Stay up to date with latest research, goals and plans. Wee need your support. Together, we must unite for clear vision.
Contact Us
© 2020 All Rights Reserved | VMR RESEARCH FOUNDATION | IRS Registration EIN: 61-1888947
